European Archives - European Medical Journal

New Clues to Early Melanoma Development

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps in skin cancer progression

Updated EAU Guidelines Transform Bladder Cancer Management

The guidelines endorse adjuvant nivolumab for patients with pT3/4 and/or pN+ disease who are unsuitable for, or have declined, cisplatin-based chemotherapy.

Dupilumab Linked to Higher Lymphoma Risk in Patients with Asthma

Dupilumab was associated with increased lymphoma risk but lower overall mortality in a large asthma cohort study.

Allergic Rhinitis Increases Risk of Depression and Anxiety

The study suggests that the inflammatory processes central to AR may also affect the brain, potentially leading to mood disturbances through mechanisms such as elevated cytokines or histamine imbalance.

Combination Therapy Shows Promise in ‘Cold’ Soft Tissue Sarcoma Trial

A new clinical trial offers insight into tackling one of the biggest challenges in soft tissue sarcomas….

Europe Urged to Improve Newborn Biliary Atresia Screening

Biliary atresia is the most common surgical cause of cholestatic jaundice in infants and the leading reason for paediatric liver transplants

Saliva Testing Identifies Early Risk for Cancer and Chronic Diseases

Saliva-based DNA markers could predict cancer, heart disease, and more—offering a non-invasive future for early diagnosis.

MVA-BN Vaccine Offers Safe Mpox Protection in At-Risk Groups

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Dupilumab Linked to Increased Psoriasis Risk in Atopic Dermatitis

Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.

Widespread Ignorance of Alcohol’s Cancer Risk

Despite alcohol being a leading preventable cause of cancer in the United States, public awareness of its cancer risk remains strikingly low, according to a new study.